Author: Lila Kensington

Urine drug screens and risk stratification help doctors monitor opioid treatment safely. But false negatives and outdated tests can mislead. Learn how to ensure accurate results and avoid unnecessary penalties.

Immunosuppressants are essential after organ transplants to prevent rejection, but they come with serious risks like infections, cancer, and organ damage. Learn how to manage these medications safely for long-term survival.

Many medications make your skin dangerously sensitive to sunlight. Learn which drugs cause photosensitivity, how to protect yourself with real sun safety tips, and why regular sunscreen often isn't enough.

Canagliflozin helps control blood sugar in type 2 diabetes but carries a rare risk of lower-limb amputation. Learn who's most at risk, what the latest evidence shows, and how to stay safe while using it.

Integrated dual diagnosis care treats mental illness and substance use together, not separately. Learn how this evidence-based approach helps millions recover by addressing both conditions with one team, one plan, and one path forward.

Authorized generics are the exact same drug as brand-name medications, made in the same factory with identical ingredients. They work just as well, cost less, and have no hidden differences. Here’s what you need to know before you switch.

Jet lag and delayed sleep phase disorder disrupt your body's natural clock. Learn how they differ, why they happen, and what actually works to fix them-without pills.

Learn how to read pharmacy labels and warning stickers to avoid dangerous medication errors. Understand FDA rules, color codes, font requirements, and what's changing in 2025 to keep you safe.

Authorized generics are identical to brand-name drugs but sold under a different label. In 2025, they’re rare due to FTC crackdowns and a shift toward biosimilars. Learn which ones are available and how to get them.

Ethnicity influences how your body processes drugs due to genetic differences in metabolism. Learn how genes like CYP2D6 and HLA-B*15:02 affect drug response across populations - and why testing, not race, is the future of safe prescribing.